YY/T 1789.5-2023In vitro diagnostic test systems - Performance evaluation method - Part 5: Analytical specificity (English PDF)
体外诊断检验系统 性能评价方法 第5部分:分析特异性
This is a limited preview
Buy now to download the full PDF (24 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1789.5-2023 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 14, 2023
Implementation date
May 1, 2024
Scope
YY/T 1789.5-2023 is the English-translated version of 体外诊断检验系统 性能评价方法 第5部分:分析特异性.
YY/T 1789.5-2023 is the Chinese standard "In vitro diagnostic test systems - Performance evaluation method - Part 5: Analytical specificity".
Its scope clause reads: This document specifies methods for evaluating the analytical specific performance of in vitro diagnostic test systems: This document is intended for use by manufacturers in evaluating the analytical specificity of in vitro diagnostic test systems for quantitative testing, based on quantitative measurements and passing Qualitative in vitro diagnostic test systems (such as enzyme-linked immunosorbent assay for pathogenic microorganism antigens or antibody detection kits) for threshold judgment results Assay specificity evaluation: This document does not apply to in vitro diagnostic test systems in which results are reported as nominal and ordinal scales, e:g: for blood cell identification, microbiological Performance evaluation of in vitro diagnostic test systems for substance identification, nucleic acid sequence identification, and urine particle identification: This document does not apply to performance verification in medical laboratories, nor does it apply to product type inspection:. Its clauses include terms and definitions.
Found what you need?
Document preview — YY/T 1789.5-2023
National Standard of the People's Republic of China
- ICS
- 11.100.10
- Classification
- C30
Issued by: National Medical Products Administration
Contents
- Preface
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
- 4 General
- 5 Evaluation by addition of interfering substances
- 6 Evaluation using clinical samples
- 7 Cross Reaction
- 8 Result presentation
- 9 Examples of Analytical Specificity
- Appendix A (informative) Example of evaluation by adding interfering substances
- Appendix B (informative) Interference evaluation (dose effect) example
- Appendix C (informative) Examples of evaluations using clinical samples
- Appendix D (informative) Cross-reactivity evaluation example
1 Scope
This document specifies methods for evaluating the analytical specific performance of in vitro diagnostic test systems:
This document is intended for use by manufacturers in evaluating the analytical specificity of in vitro diagnostic test systems for quantitative testing, based on quantitative measurements and passing
Qualitative in vitro diagnostic test systems (such as enzyme-linked immunosorbent assay for pathogenic microorganism antigens or antibody detection kits) for threshold judgment results
Assay specificity evaluation:
This document does not apply to in vitro diagnostic test systems in which results are reported as nominal and ordinal scales, e:g: for blood cell identification, microbiological
Performance evaluation of in vitro diagnostic test systems for substance identification, nucleic acid sequence identification, and urine particle identification:
This document does not apply to performance verification in medical laboratories, nor does it apply to product type inspection:
2 Normative references
The contents of the following documents constitute the essential provisions of this document through normative references in the text: Among them, dated references
For documents, only the version corresponding to the date is applicable to this document; for undated reference documents, the latest version (including all amendments) is applicable to this document:
GB/T 29791:1-2013 Information provided by manufacturers of in vitro diagnostic medical devices (labelling) Part 1: Terms, definitions and common enquiries
YY/T 1441 General Requirements for Performance Evaluation of In Vitro Diagnostic Medical Devices
WS/T 416-2013 Guidelines for interference experiments
3 Terms and Definitions
The following terms and definitions apply to this document:
3:1 interference
System effect of a measurement caused by an influencing quantity which does not itself generate a signal in the measuring system, but which causes a change in the indication increase or decrease:
NOTE: Interference to the measurement results is related to the concept of assay specificity: The more specific a measurement procedure is relative to the other components of the sample, the less susceptible it is to these
Analytical interference of compounds:
[Source: GB/T 29791:1-2013, A:3:2]
3:2
The capability of a measurement system, using a specified measurement procedure, to give measurement results for one or more measurands that are independent of each other and of the received
Any other quantity in the system being measured:
Example: The ability of a measurement system to measure plasma creatinine concentration undisturbed by glucose, uric acid, ketone bodies, or protein concentrations using the alkaline picric acid procedure:
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 24 pages — is available in the English PDF.
Referenced standards
How to Download YY/T 1789.5-2023
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 29791.1-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 1: Terms, definitions and general requirements
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
GB/T 29791.3-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 3: In vitro diagnostic instruments for professional use
Secure payment via Stripe
Payments accepted
YY/T 1789.5-2023
$465.00